サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1361770

幹細胞アッセイの世界市場レポート

Global Stem Cell Assays Market Report
出版日: | 発行: Value Market Research | ページ情報: 英文 287 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
幹細胞アッセイの世界市場レポート
出版日: 2023年10月01日
発行: Value Market Research
ページ情報: 英文 287 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

幹細胞アッセイ市場の世界需要は、2023年～2030年の調査期間中にCAGR19.82%で成長し、2022年の46億6,000万米ドルから2030年までに237億2,000万米ドル近くの市場規模に達すると推定されます。

幹細胞アッセイは、新薬研究の診断ツールとして機能性細胞を使用することで、細胞や生化学的機能を測定するために主に採用されています。幹細胞アッセイは、形や大きさなどさまざまなパラメータに基づいて生きた細胞を分析する技術を含みます。幹細胞アッセイは、細胞の成長、運動性、毒性を測定します。

市場力学：

幹細胞を用いた治療の臨床試験認可の増加、慢性疾患の高い蔓延、幹細胞に関する研究活動の活発化などが、幹細胞アッセイ市場の成長を後押ししています。さらに、先進的な医療インフラの開拓や新たな新技術の発明は、幹細胞分析市場の拡大を常に後押ししています。これに伴い、新技術の進化と患者数の増加は、予測期間中に有利な成長機会を提供します。さらに、幹細胞研究への資金提供の増加や世界のがん罹患率の上昇により、市場の拡大が見込まれています。しかし、幹細胞を分析する熟練した専門家の不足や、幹細胞分析機器の高コストが、市場の成長を阻害する可能性があります。

本調査レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは幹細胞アッセイの世界市場における各セグメントを包括的に評価することもできます。幹細胞アッセイ業界の成長と動向は、本調査に総合的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける幹細胞アッセイ市場の現在と将来の需要について、地域別の展望を取り上げます。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 幹細胞アッセイ：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 幹細胞アッセイの世界市場分析：細胞タイプ別

  • 概要：細胞タイプ別
  • 実績データと予測データ
  • 分析：細胞タイプ別
  • 成体幹細胞
  • 間葉系幹細胞
  • 人工多能性幹細胞
  • 造血幹細胞
  • 臍帯幹細胞
  • 神経幹細胞
  • ヒト胚性幹細胞

第7章 幹細胞アッセイの世界市場分析：製品・サービス別

  • 概要：製品・サービス別
  • 実績データと予測データ
  • 分析：製品・サービス別
  • 装置
  • フローサイトメーター
  • 微小電極アレイ
  • 細胞イメージング・分析システム
  • 自動セルカウンター
  • キット
  • サービス

第8章 幹細胞アッセイの世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 再生医療と治療開発
  • 整形外科、筋骨格系、脊椎への応用
  • 皮膚科領域
  • 心血管
  • 中枢神経
  • 腫瘍学
  • 糖尿病
  • その他の再生医療・治療開発
  • 創薬・医薬品開発
  • 臨床研究

第9章 幹細胞アッセイの世界市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 実績データと予測データ
  • 分析：エンドユーザー別
  • バイオ医薬品・バイオテクノロジー企業
  • 学術研究機関

第10章 幹細胞アッセイの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第11章 幹細胞アッセイ企業の競合情勢

  • 幹細胞アッセイ市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.（US）
  • Merck KGaA（Germany）
  • Danaher（US）
  • Becton
  • Dickinson and Company（US）
  • Bio-Rad Laboratories（US）
  • Promega Corporation（US）
  • Bio-Techne Corporation（US）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Cell Type (USD MN)
  • Adult Stem Cells Market Sales by Geography (USD MN)
  • Mesenchymal Stem Cells Market Sales by Geography (USD MN)
  • Induced Pluripotent Stem Cells Market Sales by Geography (USD MN)
  • Hematopoietic Stem Cells Market Sales by Geography (USD MN)
  • Umbilical Cord Stem Cells Market Sales by Geography (USD MN)
  • Neural Stem Cells Market Sales by Geography (USD MN)
  • Human Embryonic Stems Cells Market Sales by Geography (USD MN)
  • Analysis Market by Product & Service (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Flow Cytometers Market Sales by Geography (USD MN)
  • Microelectrode Arrays Market Sales by Geography (USD MN)
  • Cell Imaging & Analysis Systems Market Sales by Geography (USD MN)
  • Automated Cell Counters Market Sales by Geography (USD MN)
  • Kits Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Regenerative Medicine & Therapy Development Market Sales by Geography (USD MN)
  • Orthopedic, Musculoskeletal, And Spine Applications Market Sales by Geography (USD MN)
  • Dermatology Applications Market Sales by Geography (USD MN)
  • Cardiovascular Applications Market Sales by Geography (USD MN)
  • CNS Applications Market Sales by Geography (USD MN)
  • Oncology Applications Market Sales by Geography (USD MN)
  • Diabetes Applications Market Sales by Geography (USD MN)
  • Other Regenerative Medicine & Therapy Development Applications Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Clinical Research Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Biopharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Global Stem Cell Assays Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Stem Cell Assays Report
  • Market Research Process
  • Market Research Methodology
  • Global Stem Cell Assays Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Cell Type
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Cell Type (USD MN)
  • Adult Stem Cells Market Sales by Geography (USD MN)
  • Mesenchymal Stem Cells Market Sales by Geography (USD MN)
  • Induced Pluripotent Stem Cells Market Sales by Geography (USD MN)
  • Hematopoietic Stem Cells Market Sales by Geography (USD MN)
  • Umbilical Cord Stem Cells Market Sales by Geography (USD MN)
  • Neural Stem Cells Market Sales by Geography (USD MN)
  • Human Embryonic Stems Cells Market Sales by Geography (USD MN)
  • Global Market Analysis by Product & Service (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Flow Cytometers Market Sales by Geography (USD MN)
  • Microelectrode Arrays Market Sales by Geography (USD MN)
  • Cell Imaging & Analysis Systems Market Sales by Geography (USD MN)
  • Automated Cell Counters Market Sales by Geography (USD MN)
  • Kits Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Regenerative Medicine & Therapy Development Market Sales by Geography (USD MN)
  • Orthopedic, Musculoskeletal, And Spine Applications Market Sales by Geography (USD MN)
  • Dermatology Applications Market Sales by Geography (USD MN)
  • Cardiovascular Applications Market Sales by Geography (USD MN)
  • CNS Applications Market Sales by Geography (USD MN)
  • Oncology Applications Market Sales by Geography (USD MN)
  • Diabetes Applications Market Sales by Geography (USD MN)
  • Other Regenerative Medicine & Therapy Development Applications Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Clinical Research Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Biopharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218694

The global demand for Stem Cell Assays Market is presumed to reach the market size of nearly USD 23.72 BN by 2030 from USD 4.66 BN in 2022 with a CAGR of 19.82% under the study period 2023 - 2030.

Stem cell assays are majorly adopted for measuring cellular and biochemical functions by using functional cells as diagnostic tools in researching new drugs. Stem cell assays involve the technique for analyzing living cells based on different parameters such as shape, size, and others. Stem cell assays measure cell growth, motility, and toxicity.

MARKET DYNAMICS:

The increase in approvals of clinical trials for stem cell-based therapy, high prevalence of chronic diseases, and increase in research-related activities in stem cells supplement the growth of the stem cell assay market. Moreover, the development of advanced medical infrastructures and the invention of emerging new technology has always aided in expanding the stem cell assay market. In line with this, an increase in the evolution of new technologies and a rise in the patient pool provide lucrative market opportunities for growth during the forecast period. Furthermore, the market is expected to grow due to increased funding for stem cell research and the rising cancer incidence worldwide. However, the shortage of skilled professionals for analyzing stem cells and the high cost of stem cell analysis instruments may impede the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of stem cell assays. The growth and trends of stem cell assays industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the stem cell assays market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Cell Type

  • Adult Stem Cells
  • Mesenchymal Stem Cells
  • Induced Pluripotent Stem Cells
  • Hematopoietic Stem Cells
  • Umbilical Cord Stem Cells
  • Neural Stem Cells
  • Human Embryonic Stems Cells

By Product & Service

  • Instruments
  • Flow Cytometers
  • Microelectrode Arrays
  • Cell Imaging & Analysis Systems
  • Automated Cell Counters
  • Kits
  • Services

By Application

  • Regenerative Medicine & Therapy Development
  • Orthopedic, Musculoskeletal, And Spine Applications
  • Dermatology Applications
  • Cardiovascular Applications
  • CNS Applications
  • Oncology Applications
  • Diabetes Applications
  • Other Regenerative Medicine & Therapy Development Applications
  • Drug Discovery & Development
  • Clinical Research

By End User

  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Stem Cell Assays market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Stem Cell Assays market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Promega Corporation (US), Bio-Techne Corporation (US),. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . STEM CELL ASSAYS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Cell Type
    • 3.7.2 Market Attractiveness Analysis By Product & Service
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY CELL TYPE

  • 6.1 Overview by Cell Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Cell Type
  • 6.4 Adult Stem Cells Historic and Forecast Sales by Regions
  • 6.5 Mesenchymal Stem Cells Historic and Forecast Sales by Regions
  • 6.6 Induced Pluripotent Stem Cells Historic and Forecast Sales by Regions
  • 6.7 Hematopoietic Stem Cells Historic and Forecast Sales by Regions
  • 6.8 Umbilical Cord Stem Cells Historic and Forecast Sales by Regions
  • 6.9 Neural Stem Cells Historic and Forecast Sales by Regions
  • 6.10. Human Embryonic Stems Cells Historic and Forecast Sales by Regions

7 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY PRODUCT & SERVICE

  • 7.1 Overview by Product & Service
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product & Service
  • 7.4 Instruments Historic and Forecast Sales by Regions
  • 7.5 Flow Cytometers Historic and Forecast Sales by Regions
  • 7.6 Microelectrode Arrays Historic and Forecast Sales by Regions
  • 7.7 Cell Imaging & Analysis Systems Historic and Forecast Sales by Regions
  • 7.8 Automated Cell Counters Historic and Forecast Sales by Regions
  • 7.9 Kits Historic and Forecast Sales by Regions
  • 7.10. Services Historic and Forecast Sales by Regions

8 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Regenerative Medicine & Therapy Development Historic and Forecast Sales by Regions
  • 8.5 Orthopedic, Musculoskeletal, And Spine Applications Historic and Forecast Sales by Regions
  • 8.6 Dermatology Applications Historic and Forecast Sales by Regions
  • 8.7 Cardiovascular Applications Historic and Forecast Sales by Regions
  • 8.8 CNS Applications Historic and Forecast Sales by Regions
  • 8.9 Oncology Applications Historic and Forecast Sales by Regions
  • 8.10. Diabetes Applications Historic and Forecast Sales by Regions
  • 8.11 Other Regenerative Medicine & Therapy Development Applications Historic and Forecast Sales by Regions
  • 8.12 Drug Discovery & Development Historic and Forecast Sales by Regions
  • 8.13 Clinical Research Historic and Forecast Sales by Regions

9 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Biopharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.5 Academic & Research Institutes Historic and Forecast Sales by Regions

10 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE STEM CELL ASSAYS COMPANIES

  • 11.1. Stem Cell Assays Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF STEM CELL ASSAYS INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific Inc. (US)
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Merck KGaA (Germany)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Danaher (US)
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Becton
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Dickinson and Company (US)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Bio-Rad Laboratories (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Promega Corporation (US)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Bio-Techne Corporation (US)
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies